Literature DB >> 23516310

Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.

Osamu Manabe1, Naoya Hattori, Kenji Hirata, Kazuo Itoh, Masao Hosokawa, Hiroaki Takahashi, Noriko Oyama-Manabe, Nagara Tamaki.   

Abstract

UNLABELLED: The metabolic activity of the primary tumor is an important variable in (18)F-FDG PET interpretation for presurgical staging, because this activity is likely to affect the possibility of detection of malignant involvement in lymph nodes (LNs). The purpose of this study was to reevaluate the diagnostic accuracy of (18)F-FDG PET/CT for the presurgical staging of esophageal squamous cell carcinoma (SCC) in correlation with the (18)F-FDG avidity of the primary lesions.
METHODS: One hundred fifty-six patients (mean age ± SD, 61.4 ± 8.0 y) underwent (18)F-FDG PET/CT before surgical esophagectomy and LN dissection. LN metastasis was identified using the fusion of PET and CT images with increased (18)F-FDG uptake greater than the background activity of the adjacent structures. The results of the patients' (18)F-FDG PET/CT examinations for LN involvement were compared with the histopathologic results to investigate the diagnostic accuracy of (18)F-FDG PET/CT for tumor staging. In addition, we examined the correlation between the diagnostic accuracy of (18)F-FDG PET/CT for LN involvement and the (18)F-FDG avidity of the primary lesions, to investigate the effect of tumor aggressiveness on the diagnosis of LN metastasis.
RESULTS: The diagnostic accuracy of (18)F-FDG PET/CT for LN metastasis showed a low sensitivity, ranging from 29.3% to 53.3%, whereas the specificity was higher than 89.8% in regional thoracic nodes and in remote areas of the cervical and abdominal regions. The (18)F-FDG uptake of the primary lesions positively correlated with that of the metastatic LNs in the thoracic field (R = 0.52, P < 0.05). As a result, our receiver-operating-characteristic analyses demonstrated an area under the curve value of 0.73, with the optimal cutoff value at a maximum standardized uptake value of 3.3 in patients with mid to high (18)F-FDG avidity in the primary lesions (maximum standardized uptake value ≥ 5).
CONCLUSION: This study showed that the avidity of the primary esophageal SCCs affected the detectability of lymph nodal metastases. If primary lesions of esophageal SCC present with a low (18)F-FDG uptake, PET/CT may have a limited role for initial staging because of low sensitivity to detect lymph node metastases.

Entities:  

Keywords:  FDG PET; esophageal cancer; pathology; squamous cell carcinoma

Mesh:

Substances:

Year:  2013        PMID: 23516310     DOI: 10.2967/jnumed.112.110304

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer.

Authors:  Jae Kil Park; Jae Jun Kim; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 2.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

3.  Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes.

Authors:  Sohyun Park; Jin Chul Paeng; Chang Hyun Kang; Gi Jeong Cheon; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

4.  Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Chenxue Jiang; Yun Chen; Yaoyao Zhu; Yapping Xu
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

5.  Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.

Authors:  Brandon Garcia; Karyn A Goodman; Lajhem Cambridge; Mark Dunphy; Abraham J Wu
Journal:  Radiat Oncol       Date:  2016-11-25       Impact factor: 3.481

6.  FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.

Authors:  Pavel Fencl; Otakar Belohlavek; Tomas Harustiak; Milada Zemanova
Journal:  Abdom Radiol (NY)       Date:  2016-11

7.  FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy.

Authors:  Yung-Cheng Huang; Hung-I Lu; Shun-Chen Huang; Chien-Chin Hsu; Nan-Tsing Chiu; Yu-Ming Wang; Yi-Chun Chiu; Shau-Hsuan Li
Journal:  BMC Med Imaging       Date:  2017-01-05       Impact factor: 1.930

8.  Measuring distance from the incisors to the esophageal cancer by FDG PET/CT: endoscopy as the reference.

Authors:  Szu-Wei Hsu; Jeffrey S Chang; Wei-Lun Chang; Forn-Chia Lin; Nan-Tsing Chiu
Journal:  BMC Gastroenterol       Date:  2022-03-17       Impact factor: 3.067

9.  Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.

Authors:  Amos J M Ela Bella; Ya-Rui Zhang; Wei Fan; Kong-Jia Luo; Tie-Hua Rong; Peng Lin; Hong Yang; Jian-Hua Fu
Journal:  Chin J Cancer       Date:  2014-02-14

10.  Usefulness of positron emission tomography-computed tomography in pre-operative evaluation of intra-thoracic esophageal cancer.

Authors:  Jae Jun Kim; Jae Kil Park; Seok Whan Moon
Journal:  Thorac Cancer       Date:  2015-03-06       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.